Tranquil Mind — honokiol, saffron and a gut-derived strain
Three actives with real pharmacology behind them, in the newest product in the catalogue. Here is what is in it and what the listing does and does not tell you.
Affiliate disclosure.We earn a commission if you buy through links on this page, at no extra cost to you. It does not change what we recommend, and we say so when we think you should not buy.
What it is
A capsule combining three things: honokiol, a compound from magnolia bark; saffron extract; and a bacterial strain the manufacturer describes as GABA-producing.
Ninety capsules, $75 — about 83 cents each.
Why people consider it
Because the ingredient list is unusual, and not in a decorative way. These are three genuinely different approaches to the same area, put in one capsule.
Honokiol is a real pharmacological subject. It is a biphenol from Magnolia officinalis studied as a modulator of GABA-A receptors — the same receptor family that sedative drugs act on. Most of that work is preclinical, in cells and rodents, and human data at consumer doses is limited. But it is a characterised molecule with a mechanism, not a botanical chosen for the label.
Saffron has the strongest human evidence of the three. Randomised controlled trials exist for mood outcomes and are reasonably well conducted.
A GABA-producing bacterial strain approaches the same territory from the gut. Some gut bacteria do produce GABA, and the gut-brain axis is an active and legitimate research area.
Three mechanisms, one capsule. That is the reason someone picks this off a shelf.
What makes this one interesting
It is the newest product in the catalogue — published in May 2026 — and it is the only one built around this particular combination.
It is also the most expensive supplement here per capsule, which is worth knowing up front rather than discovering at checkout.
The thing we would want before recommending it more strongly is a label panel. The ingredients are named; the amounts are not. That matters more here than it would elsewhere, because saffron’s trial evidence is tied to a standardised extract at a specific daily dose — so without a figure, the research and the product cannot be connected to each other. We have deliberately not cited those trials on this page for that reason.
If the manufacturer publishes doses and a strain designation, this becomes a product we could evaluate properly. Both are things they could publish tomorrow.
Key facts
| Price | $75 when last checked — not confirmed as current |
|---|---|
| Count | 90 per bottle |
| Cost per unit | Not quoted — depends on the current price, which we have not confirmed |
| Serving size | Not published on the listing |
| Contains | Honokiol (Magnolia officinalis) · Saffron extract · GABA-producing psychobiotic strain |
| Certificate of analysis | Not published |
| Availability | In stock when checked on 2026-09-04 — that reading is now out of date |
Who it may suit
- You are interested in honokiol or saffron specifically and would rather try them formulated together than source three things separately.
- You want a stress-and-calm product built on characterised compounds rather than a generic herbal blend.
- You have read the ingredient list, understand the amounts are not published, and are comfortable on that basis.
Less of a fit if…
- You want to match a dose used in published research. The amounts are not published here, so you cannot.
- You take psychoactive medication. See the note at the top of this page.
- You want the cheapest way to try saffron or magnolia bark. Single-ingredient products cost a fraction of this and state the dose.
- What you are dealing with feels clinical rather than ordinary. That is a conversation for a doctor, and no capsule is the answer to it.
Worth knowing before you buy
What we verified
10 statements on this page are tiered and traced to a source. Manufacturer statements are labelled as manufacturer statements rather than repeated as findings.
Show the evidence table
Where each claim on this page comes from
Every factual statement above is listed here with its source. Rows marked “manufacturer claim” are the manufacturer’s description of its own product, reported without endorsement.
| Tier | Claim | Kind | Source |
|---|---|---|---|
| E | Honokiol is a biphenol compound from Magnolia officinalis studied as a modulator of GABA-A receptors, predominantly in preclinical models. | External source | Peer-reviewed pharmacology literature on honokiol receptor activity
Population: Preclinical (cell and rodent models); described as preclinical on the page |
| E | Probiotic effects are strain-specific, so a functional description without a strain designation cannot be matched to published research. | External source | International Scientific Association for Probiotics and Prebiotics consensus on probiotic definition and strain specificity
Population: General population; consensus methodology statement |
| B | The product is a single 90-capsule variant priced at $75.00 and available at the 2026-09-04 inventory check. | Specification | MitoLife storefront inventory endpoint, retrieved 2026-09-04 |
| B | At $75 for 90 capsules the unit cost is $0.83 per capsule, the highest per-capsule price in the catalogue. | Specification | Arithmetic across all catalogue prices verified 2026-09-04 |
| B | No dose is published for the saffron extract, the honokiol content, or the bacterial strain and its CFU count. | Specification | MitoLife product page and inventory endpoint, retrieved 2026-09-04 |
| B | Serving size is not published, so cost per serving cannot be calculated. | Specification | MitoLife storefront listing, retrieved 2026-09-04 |
| B | The product was published to the storefront on 2026-05-14, making it the most recently listed product in the catalogue. | Specification | MitoLife inventory endpoint published_at field, retrieved 2026-09-04 |
| A | The manufacturer states the formula contains honokiol, saffron and a GABA-producing psychobiotic. | Manufacturer statement | MitoLife product page copy, retrieved 2026-09-04 Manufacturer statement, not independently verified. |
| F | Our view: because no dose is published for any active, the saffron mood-trial literature cannot be connected to this product, and citing it would lend the product evidence it has not been shown to earn. | Our editorial view | Stage 1 claims governance, attribution rule 1 Our view: this is our editorial judgement, not a finding. |
| F | Our view: three plausible ingredients with no verifiable amounts is the central fact a buyer needs before spending $75. | Our editorial view | Editorial assessment Our view: this is our editorial judgement, not a finding. |
Others in Rest & Calm
See all →Melatonin
Two doses, 5 mg and 50 mg — and the gap between them is the decision.
Price not current Needs re-checkingOur price and stock reading for this product is out of date, so we are not presenting it as current. The rest of this page still stands.
Read the review